Benzonatate Capsule
Product Images NDC 64380-712

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 64380-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4a8b8e96 801e 49de Badb 7be3fbf57baa 01

FDA Label Image

4a8b8e96 801e 49de Badb 7be3fbf57baa 02

4a8b8e96 801e 49de Badb 7be3fbf57baa 02
This is a medication called Benzonatate, USP contained in soft gelatin capsules. It is manufactured by Strides Pharma Science Ltd, in Bengaluru - 562106, India and distributed by Strides Pharma Inc. The capsules must not be broken, chewed, dissolved, cut or crushed and must be swallowed whole. See accompanying prescribing information for dosage and use. It should be stored at 20° to 25°C and protected from light. The text also includes information on the NDC number, lot number, and revised date. There is a code for batch details and a warning about using the product outside the specified temperature range.*
FDA Label Image

4a8b8e96 801e 49de Badb 7be3fbf57baa 03

4a8b8e96 801e 49de Badb 7be3fbf57baa 03
Each soft gelatin capsule contains 200 mg of Benzonatae USP. The Dosage and use information is available in the accompanying prescribing information. Patients should swallow the Benzonatae capsules whole and should not break, chew, dissolve, or crush them. The capsules should be stored between 20-25°C, with excursions permitted from 15-30°C. This drug should be protected from light. It is manufactured by Strides Pharma Science Ltd in Bengaluru, India, and distributed by Strides Pharma Inc. in East Brunswick, NJ. The code number is KRUDRUGSIKTK/25/415/98.*
FDA Label Image

4a8b8e96 801e 49de Badb 7be3fbf57baa 04

4a8b8e96 801e 49de Badb 7be3fbf57baa 04
This is a medication called Benzonatate, USP contained in soft gelatin capsules. Each capsule contains 100 mg of Benzonatate, USP. It is advised to swallow the capsule whole and not to break, chew, dissolve, cut, or crush it. The medication must be stored at 20° to 25°C (68° to 77°F), and it is recommended to be dispensed in a tight (USP), child-resistant containers. This medication is manufactured by Strides Pharma Science Limited in Bengaluru, India, and distributed by Strides Pharma Inc. in East Brunswick, N 08816. The revision date of prescribing information is in 07/2019.*
FDA Label Image

4a8b8e96 801e 49de Badb 7be3fbf57baa 05

4a8b8e96 801e 49de Badb 7be3fbf57baa 05
This text is prescribing information for Benzonatate USP capsules. Patients should swallow the capsules whole, without breaking, chewing, dissolving, cutting, or crushing them. The capsules should be stored at 20° to 25°C (68° to 77°F) and protected from light, with excursions permitted to 15-30°C (50-86°F). The medication is distributed by Strides Pharma Inc. and manufactured by Strides Pharma Science Limited in Bengaluru, India. The medication should be dispensed in tight (USP), child-resistant containers. Revised prescribing information is available as of 07/2019.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.